Date: 2014-11-17
Type of information: Distribution agreement
Compound: Brinavess® (vernakalant intravenous)
Company: Cardiome Pharma (Canada) Aspen Pharmacare (South Africa)
Therapeutic area: Cardiovascular diseases
Type agreement: distribution
Action mechanism:
Disease:
Details: * On November 17, 2014, Cardiome Pharma announced that an affiliate of the company has entered into an agreement with Pharmacare Limited, which trades as Aspen Pharmacare and is a part of the Aspen Group, to sell and distribute Brinavess® (vernakalant intravenous) exclusively in South Africa. Under the terms of the agreement, Aspen has agreed to specific annual commercial goals for Brinavess®.
Financial terms: Financial details of the agreement have not been disclosed.
Latest news:
